Regulating Short-Term Volatility Will Harm Pharmaceutical Innovation – Forbes

Regulating Short-Term Volatility Will Harm Pharmaceutical Innovation
Forbes
In misplaced attempts to address the problems with the U.S. health care industry, many analysts point to specific list price increases on specialty pharmaceutical drugs to claim that high drug prices are driving overall health care costs ever higher.

and moreĀ >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd